This study is currently not recruiting participants.

Retrospective analysis of PET scan Standard Uptake Values (SUV) for post-chemotherapy retroperitoneal lymph node dissection patients

Investigating PET Scan Values After Chemotherapy

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to examine SUV values on PET scans for patients who have undergone a post-chemotherapy retroperitoneal lymph node dissection in order to determine whether or not preoperative PET scan SUV values can be used to determine statistically significant cut-points which will indicate the likelihood of residual retroperitoneal masses to be cancer or necrosis.

Detailed description of study

The purpose of this study is to examine SUV values on PET scans for patients who have undergone a post-chemotherapy retroperitoneal lymph node dissection in order to determine whether or not preoperative PET scan SUV values can be used to determine statistically significant cut-points which will indicate the likelihood of residual retroperitoneal masses to be cancer or necrosis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to examine SUV values on PET scans for patients who have undergone a post-chemotherapy retroperitoneal lymph node dissection. The study aims to find out if the SUV values from PET scans taken before surgery can help predict whether remaining masses in the retroperitoneal area are cancerous or not. SUV stands for Standardized Uptake Value, which is a measure used in PET scans to show how much tracer a tissue absorbs, indicating possible cancer activity.

Participants will undergo PET scans to measure SUV values. The study will analyze these values to find statistically significant cut-points that might indicate if the masses are cancerous or just necrosis, which means dead tissue.

  • Who can participate: This study is for patients aged 18 and older who have had a retroperitoneal lymph node dissection after chemotherapy.
  • Study details: Participants will have PET scans to measure SUV values. These values will be analyzed to find cut-points indicating if masses are cancerous or necrotic. A placebo is an inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1606117540

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team